These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4579520)

  • 21. Measurement of immune complexes in insulin-treated diabetics.
    Jayarao KS; Faulk WP; Karam JH; Grodsky GM; Forsham PH
    J Immunol Methods; 1973 Dec; 3(4):337-45. PubMed ID: 4591347
    [No Abstract]   [Full Text] [Related]  

  • 22. [Free, total and antibody-bound insulin content in newly detected diabetes mellitus patients].
    Mosin VI; Morozova NN; Salanda BS
    Probl Endokrinol (Mosk); 1980; 26(5):6-11. PubMed ID: 7001439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of serum insulin during fasting and glucose loading before and after treatment of diabetes].
    Kosaka K; Hagura R; Ogawara H
    Dtsch Med J; 1970 Apr; 21(8):554-64. PubMed ID: 5510200
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 25. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics.
    Sekso M; Resetić J; Riznar V; Solter M
    Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antibodies to insulin in patients with diabetes mellitus].
    Kozopolianskaia MM; Poltorak VV; Stetsenko KP
    Vrach Delo; 1973 Feb; 2():110-2. PubMed ID: 4722307
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical significance of insulin antibodies.
    Andersen OO; Egeberg J
    Acta Paediatr Scand Suppl; 1977; (270):63-8. PubMed ID: 278469
    [No Abstract]   [Full Text] [Related]  

  • 28. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin antibodies in diabetes.
    Lev-Ran A; Joshua H; Mannheimer S
    Isr J Med Sci; 1971 Sep; 7(9):1035-9. PubMed ID: 5170197
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of free and total insulin in insulin-treated diabetics].
    Wójcikowski C
    Endokrynol Pol; 1976; 27(1):63-70. PubMed ID: 1253761
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioimmunoassay: its relevance to diabetes mellitus.
    Yalow RS
    Diabetes Care; 1981; 4(1):47-53. PubMed ID: 7009114
    [No Abstract]   [Full Text] [Related]  

  • 34. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radioimmunoassay of insulin].
    Horiuchi T
    Nihon Naibunpi Gakkai Zasshi; 1966 Aug; 42(5):467-74. PubMed ID: 4290997
    [No Abstract]   [Full Text] [Related]  

  • 36. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunogenic properties of a highly purified insulin preparation.
    Manning NT; Drury MI
    Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.
    Gennaro WD; Van Norman JD
    Clin Chem; 1975 Jun; 21(7):873-9. PubMed ID: 236845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.